January 13, 2025 11:46 AM EST
R&D
Pharma

Ab­b­Vie part­ners with Sim­cere Phar­ma unit to de­vel­op myelo­ma drug

Alexis Kramer

Pharma Editor

Ab­b­Vie is team­ing up with Sim­cere Za­im­ing to de­vel­op an in­ves­ti­ga­tion­al new drug can­di­date for mul­ti­ple myelo­ma.

The agree­ment, an­nounced Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Mod­er­na low­ers 2025 rev­enue es­ti­mate, an­nounces more cost cuts

#JPM25 live blog: How will Trump 2.0 im­pact the bio­phar­ma in­dus­try? Scott Got­tlieb, Bob Nelsen share per­spec­tives

Up­dat­ed: J&J to buy In­tra-Cel­lu­lar for $14.6B in lat­est neu­ro­science bet

Lil­ly to ac­quire can­cer biotech Scor­pi­on, which shares a co-founder with Loxo

Got­tlieb says RFK Jr. as HHS sec­re­tary could bring ‘trag­ic’ out­breaks

BIO CEO plans to join FDA mod­ern­iza­tion ad­vi­so­ry board un­der Trump ad­min­is­tra­tion

A service from the Financial Times